DOWN-REGULATION OF C-MYC GENE-EXPRESSION WITH INDUCTION OF HIGH-MOLECULAR-WEIGHT DNA FRAGMENTS BY FLUORODEOXYURIDINE

被引:0
作者
LI, ZR
YIN, MB
ARREDONDO, MA
SCHOBER, C
RUSTUM, YM
机构
[1] ROSWELL PK CANC INST,GRACE CANC DRUG CTR,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[2] ROSWELL PK CANC INST,DEPT SURG ONCOL,BUFFALO,NY 14263
[3] UNIV HANNOVER,SCH MED,DEPT HEMATOL ONCOL,W-3000 HANNOVER,GERMANY
关键词
FLUORODEOXYURIDINE; THYMIDYLATE SYNTHASE; DNA FRAGMENTATION; C-MYC GENE EXPRESSION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
5-Fluoro-2'-deoxyuridine (FdUrd), a potent inhibitor of thymidylate synthase, induces extensive bulk DNA damage at drug concentrations that produce significant in vitro growth inhibition of human ileocecal carcinoma (HCT-8) cells. Constant- and pulsed-field gel electrophoresis (CFGE and PFGE), to detect size distribution of DNA double-strand breaks and repair kinetics, in parallel with northern and western blot analyses, to quantitate c-myc gene and protein expression, were utilized to analyze drug effects. At 24-hr post in vitro drug treatment, when maximum bulk DNA damage was detected, FdUrd produced a broad range of high molecular weight DNA fragments, clustering between 0.1 and 5.7 megabases in size, and resulted in a decrease in the level of c-myc transcripts and protein with no significant effect on the level of v-myc and H-ras. These effects preceded the observed cellular growth inhibition. Addition of the reduced folate leucovorin potentiated the effects induced by FdUrd, indicating that thymidylate synthase inhibition is an important initial step in drug effect followed by DNA fragmentation and suppression of c-myc expression. Changes in the integrity of the genetic materials and regulatory genes occurred prior to the observed cell growth inhibition by FdUrd, suggesting that these molecular alterations by FdUrd may be associated with subsequent FdUrd-induced cell growth inhibition.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 41 条
  • [1] ARREDONDO M A, 1991, Proceedings of the American Association for Cancer Research Annual Meeting, V32, P28
  • [2] THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA
    BATTEY, J
    MOULDING, C
    TAUB, R
    MURPHY, W
    STEWART, T
    POTTER, H
    LENOIR, G
    LEDER, P
    [J]. CELL, 1983, 34 (03) : 779 - 787
  • [3] BERTRAND R, 1991, CANCER RES, V51, P6280
  • [4] VARIATIONS IN PATTERNS OF DNA DAMAGE INDUCED IN HUMAN COLORECTAL TUMOR-CELLS BY 5-FLUORODEOXYURIDINE - IMPLICATIONS FOR MECHANISMS OF RESISTANCE AND CYTOTOXICITY
    CANMAN, CE
    TANG, HY
    NORMOLLE, DP
    LAWRENCE, TS
    MAYBAUM, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10474 - 10478
  • [5] POSTTRANSCRIPTIONAL REGULATION OF C-MYC PROTOONCOGENE EXPRESSION AND GROWTH-INHIBITION BY RECOMBINANT HUMAN INTERFERON-BETA SER17 IN A HUMAN COLON-CARCINOMA CELL-LINE
    CHATTERJEE, D
    SAVARESE, TM
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (01) : 12 - 20
  • [6] CHATTERJEE D, 1989, CANCER RES, V49, P3910
  • [7] CHENG Y, 1983, MOL PHARMACOL, V23, P171
  • [8] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [9] CURTIN NJ, 1991, CANCER RES, V51, P2346
  • [10] FLUORINATED PYRIMIDINES AS TIGHT-BINDING INHIBITORS OF THYMIDYLATE SYNTHETASE
    DANENBERG, PV
    LOCKSHIN, A
    [J]. PHARMACOLOGY & THERAPEUTICS, 1981, 13 (01) : 69 - 90